US Stock MarketDetailed Quotes

ASND Ascendis Pharma A/S

Watchlist
  • 125.760
  • +0.940+0.75%
Trading May 15 11:42 ET
7.26BMarket Cap-13104P/E (TTM)

Ascendis Pharma A/S Key Stats

Ascendis Pharma A/S Earnings Date

Currency: EUR

Period

Q1 FY2024 Earnings

May 2, 2024

Revenue(YoY)

95.89M

+185.49%
EPS(YoY)

-2.30

-16.16%

Strong Buy

May 15, 2024

Ascendis Pharma A/S Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 112.357M--
--2024/Q2-- / 88.685M--
May 2, 20242024/Q195.894M / 81.699M--
Feb 7, 20242023/Q4137.703M / 85.606M--
Nov 7, 20232023/Q348.034M / 47.991M--
Sep 5, 20232023/Q247.393M / 37.365M--
Apr 27, 20232023/Q133.589M / 21.525M--
Feb 16, 20232022/Q422.896M / 18.846M--
Nov 2, 20222022/Q315.290M / 8.809M--
Aug 10, 20222022/Q26.160M / 5.810M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 112.357M--
--2024/Q2-- / 88.685M--
May 2, 20242024/Q195.894M / 81.699M--
Feb 7, 20242023/Q4137.703M / 85.606M--
Nov 7, 20232023/Q348.034M / 47.991M--
Sep 5, 20232023/Q247.393M / 37.365M--
Apr 27, 20232023/Q133.589M / 21.525M--
Feb 16, 20232022/Q422.896M / 18.846M--
Nov 2, 20222022/Q315.290M / 8.809M--
Aug 10, 20222022/Q26.160M / 5.810M--

Unlock Free Earnings Estimates

Ascendis Pharma A/S Earnings Reports

Read more

Analysis

Analyst Rating

Updated: May 15, 2024

Strong Buy

  • Buy

    83.33%
  • Hold

    16.67%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg